The Japanese development agency is stepping beyond traditional grants, joining VCs and corporate giants to finance the expansion of a Ghanaian "phygital" healthcare provider.
Simon Hazell returns to the CEO seat at Bioshroom, betting on high-margin wellness over commodity protein after energy crises and strategic missteps shuttered his previous agritech venture.
The Nasdaq-listed South African fintech has quietly added another small enterprise-focused company to its portfolio, paying cash for a fintech business as it continues to widen its offering for large-scale clients.
The Egyptian investment bank is carving out a reputation as the region's most prolific corporate incubator, following last year's blockbuster valU IPO with a listing request for its K‑12 education platform - but a jittery market will test investor appetite.
